O'Shaughnessy Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$15.3M Sell
34,259
-1,341
-4% -$597K 0.1% 225
2025
Q1
$17.3M Buy
35,600
+6,446
+22% +$3.13M 0.14% 171
2024
Q4
$11.7M Buy
29,154
+472
+2% +$190K 0.1% 211
2024
Q3
$13.9M Buy
28,682
+4,287
+18% +$2.08M 0.12% 184
2024
Q2
$11.4M Buy
24,395
+4,697
+24% +$2.2M 0.12% 190
2024
Q1
$8.23M Buy
19,698
+3,629
+23% +$1.52M 0.09% 256
2023
Q4
$6.54M Buy
16,069
+2,761
+21% +$1.12M 0.09% 260
2023
Q3
$4.63M Buy
13,308
+3,246
+32% +$1.13M 0.07% 300
2023
Q2
$3.54M Buy
10,062
+2,296
+30% +$808K 0.05% 336
2023
Q1
$2.45M Sell
7,766
-710
-8% -$224K 0.04% 405
2022
Q4
$2.45M Buy
8,476
+490
+6% +$142K 0.04% 389
2022
Q3
$2.31M Buy
7,986
+2,524
+46% +$731K 0.04% 371
2022
Q2
$1.54M Buy
5,462
+2,239
+69% +$631K 0.03% 443
2022
Q1
$841K Buy
3,223
+1,722
+115% +$449K 0.01% 573
2021
Q4
$330K Buy
1,501
+498
+50% +$109K 0.01% 834
2021
Q3
$182K Buy
1,003
+78
+8% +$14.2K ﹤0.01% 1089
2021
Q2
$187K Sell
925
-396
-30% -$80.1K ﹤0.01% 1061
2021
Q1
$284K Sell
1,321
-416
-24% -$89.4K 0.01% 793
2020
Q4
$411K Sell
1,737
-382
-18% -$90.4K 0.01% 577
2020
Q3
$577K Buy
2,119
+305
+17% +$83.1K 0.02% 415
2020
Q2
$527K Buy
1,814
+1,559
+611% +$453K 0.02% 389
2020
Q1
$61K Sell
255
-239
-48% -$57.2K ﹤0.01% 738
2019
Q4
$108K Buy
494
+493
+49,300% +$108K ﹤0.01% 776
2019
Q3
$0 Hold
1
﹤0.01% 1263
2019
Q2
$0 Buy
+1
New ﹤0.01% 1232